Anavex Life Sciences
AVXL
#9984
Rank
โ‚น7.08 B
Marketcap
โ‚น76.47
Share price
-12.42%
Change (1 day)
-75.91%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -โ‚น1.15 Billion

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น3.75 Billion, an increase over its 2024 earnings that were of -โ‚น4.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น1.15 Billion-69.36%
2025 -โ‚น3.75 Billion-22.43%
2024 -โ‚น4.83 Billion14.77%
2023 -โ‚น4.21 Billion-17.49%
2022 -โ‚น5.1 Billion22.96%
2021 -โ‚น4.15 Billion35.36%
2020 -โ‚น3.06 Billion12.65%
2019 -โ‚น2.72 Billion29.09%
2018 -โ‚น2.11 Billion36.33%
2017 -โ‚น1.55 Billion17.11%
2016 -โ‚น1.32 Billion20.91%
2015 -โ‚น1.09 Billion-6.29%
2014 -โ‚น1.17 Billion337.28%
2013 -โ‚น0.27 Billion
2008 -โ‚น0.5 Billion106.01%
2007 -โ‚น0.24 Billion8848.98%
2006 -โ‚น2.67 Million-79.99%
2005 -โ‚น13.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น5.69 B-570.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น10.37 B-956.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น0.79 Billion-35.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น33.18 Billion 2,638.61%๐Ÿ‡บ๐Ÿ‡ธ USA